Baku, May 5, AZERTAC
A biotech company based in Philadelphia has gotten approval to try reawakening nervous systems in patients who've been declared clinically dead, a move one doctor called "another step towards the eventual reversal of death in our lifetime”, according to nydailynews.
The trial, which will take place in India, will involve 20 patients who are brain dead and have been kept on life support, according to The Telegraph.
Scientists will try a combination of new therapies, including stem cell injections into the brain, lasers and nerve stimulation techniques that have worked to awaken comatose patients.
The test subjects will be monitored for a few months as researchers look for signs of regeneration in the central nervous system, and particularly the upper spinal cord, which controls breathing and heartbeat.